West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan 610041, China.
West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan 610041, China; Clinical research center, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Int J Nurs Stud. 2021 Jun;118:103924. doi: 10.1016/j.ijnurstu.2021.103924. Epub 2021 Mar 9.
The role of conservative versus liberal oxygen therapy for acutely ill patients remains controversial.
To systematically review the available evidence regarding the efficacy and safety of conservative oxygen therapy compared with liberal oxygen therapy for acutely ill patients.
A systematic search of Medline, Embase, and the Cochrane Central Register was conducted from their inception until April 5, 2020. Randomized clinical trials evaluating a high-target (liberal) or a low-target (conservative) oxygenation strategy in adults with an acutely ill condition were eligible for inclusion. A meta-analysis using random-effects models was conducted to calculate the risk ratio with corresponding 95% confidence intervals. Heterogeneity and publication bias were evaluated.
The analyses included 33 randomized clinical trials with a total of 17,780 participants. Compared with conservative oxygen therapy, liberal oxygen therapy was not associated with increased mortality at 30 days (risk ratio 1.09, 95% confidence intervals 0.98-1.22; I=0%), at 90 days (risk ratio 1.00, 95% confidence intervals 0.88-1.13, I=37%), or at the longest follow-up (risk ratio 1.04, 95% confidence intervals 0.96-1.12, I=0%). Good functional outcome was similar between groups. Findings were robust to trial sequential, subgroup, and sensitivity analyses.
Compared with liberal oxygen therapy, conservative oxygen therapy was not associated with decreased mortality. Tweetable abstract: Compared with liberal oxygen therapy, conservative oxygen therapy was not associated with decreased mortality.
急性病患者的保守氧疗与宽松氧疗的作用仍存在争议。
系统评价比较急性病患者保守氧疗与宽松氧疗的疗效和安全性的现有证据。
系统检索 Medline、Embase 和 Cochrane 中央注册库,检索时间截至 2020 年 4 月 5 日。纳入评估急性病成人高目标(宽松)或低目标(保守)氧合策略的随机临床试验。采用随机效应模型进行荟萃分析,计算风险比及其相应的 95%置信区间。评估异质性和发表偏倚。
分析纳入 33 项随机临床试验,共计 17780 名参与者。与保守氧疗相比,宽松氧疗在 30 天(风险比 1.09,95%置信区间 0.98-1.22;I²=0%)、90 天(风险比 1.00,95%置信区间 0.88-1.13,I²=37%)或最长随访时间(风险比 1.04,95%置信区间 0.96-1.12,I²=0%)时死亡率均无增加。两组间良好的功能结局相似。研究结果在试验序贯分析、亚组分析和敏感性分析中稳健。
与宽松氧疗相比,保守氧疗并未降低死亡率。
与宽松氧疗相比,保守氧疗并未降低死亡率。